Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Brainsway Gets FDA Approval for Multi-Center Bipolar Trial

Nov. 1 (Bloomberg) -- Brainsway Ltd. said it received approval from the U.S. Food and Drug Administration to begin a multi-center trial to test the efficacy of its Deep TMS device for the treatment of bipolar disorder, according to a filing today with the Tel Aviv Stock Exchange.

Link to Company News:{3400398Z US <Equity> CN <GO>} Link to Company News:{BRIN IT <Equity> CN <GO>}

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Alisa Odenheimer at aodenheimer@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.